Guo, Jun-Xiu <br/><br/>
Bioactivity and safety of chimeric switch receptor T cells in glioblastoma patients.  [electronic resource] 

 -  Frontiers in bioscience (Landmark edition)  06 2019 
 - 1158-1166 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2768-6698 
<br/><br/><label>Standard No.: </label>10.2741/4772  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Brain Neoplasms--immunology<br/>Female<br/>Glioblastoma--immunology<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Interferon-gamma--blood<br/>Interleukin-6--blood<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Receptors, Chimeric Antigen--immunology<br/>Treatment Outcome